Faculty of Medicine (FMUP)
Porto, 4200-319, Portugal
Location status: Recruiting
NCT Number: NCT06816225
Sleep is a neurophysiological active process essential for healthy physical and cognitive development. In Portugal, there is no recent and objective data on how children sleep.
Given the importance of sleep in child health and development as well as the health gains achieved by establishing healthy sleep patterns since childhood, it seems extremely relevant to assess the various sleep parameters of Portuguese children and correlate them with their psychomotor and anthropometric development indicators. The results of this research work may support the implementation of sleep health education measures among parents, educators and policy makers, thus contributing to support the implementation of practices that promote sleep quality, napping until later in life as well as to promote the health of future adults.
Interested in participating?
Request Info2 year–4 year
All sexes
Observational
Porto, 4200-319, Portugal
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Actigraphy is a validated complementary means of diagnosis, the gold standard for the assessment of circadian rhythm.
Assessment scale for skills in child development from 0 to 6 years.
Questionnaire for assessing sleep habits, validated for the Portuguese population (4) which allows us to understand the sleep hygiene habits of the child
Melatonin will be measured in the first-morning urine and it is considered to be a good marker of plasma MLT level since its concentration is highly correlated with nocturnal plasma melatonin.
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
Sleep patterns based on movement tracking by sleep actigraphy.
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
The psychomotor developmental coefficient obtained through the application of the evaluation tool Schedule of growing skills II (SGS II) development scale.
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
Sleep hygiene data obtained through the application of the Children Sleep habits questionnaire validated for the Portuguese population.
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
Levels of 6-sulphatoxymelatonin-aMT6, melatonin metabolite, measured in urine.
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
Weight [kg, kilogram] and height [m, meter] at the date of the evaluation for BMI-for-age calculation
Time frame: At 24 - 30 months of age, at 3 years of age and at 4 years of age
Number of infectious events in the first year of life and previous year of the following assessments.
Time frame: At 24 - 30 months of age
Questionnaire about demographic parameters and lifestyle of the parents and family:
Age group (less than 24 years; 24-29; 30-35; 35-40; more than 40); Household; Level of education; Profession; Shift work; Smoking habits; Diet (omnivore, vegetarian, ovolactovegetarian, vegan or other); Average bedtime; Average total sleeping time; Sleep schedules between weekdays and the weekend; Chronotype; History of sleep disturbances; Vitamin supplementation during pregnancy; History of postpartum depression.
Time frame: At 24 - 30 months of age
Questionnaire about the medical history and biometrics of the child:
Gestational age at birth; APGAR index; Weight [kg, kilogram], length [meter, m] and head circumference [centimeter, cm] at birth; Type of feeding (breast milk, adapted milk or mixed feeding); Daycare attendance.
Contact information is provided by the study sponsor or research team.
Andreia Neves, PhDc
CONTACT
(+351) 225513624
Janete Santos, PhD
CONTACT
(+351) 225 513 600
Universidade do Porto
Other
Acronym: SleePsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01778504
Autism Spectrum Disorder, Autistic Disorder
Bethesda, Maryland, United States
View Trial DetailsNCT07489417
Blood Pressure, Sleep
Columbia, Missouri, United States
View Trial DetailsNCT07729930
Arthralgia, Blood Pressure and Augmentation Index
Loughborough, United Kingdom
View Trial DetailsNCT07411222
Behavior, Bipolar Disorder
Bolu, Turkey (Türkiye)
View Trial Details